POST-CONFERENCE WORKSHOP DAY

Thursday | November 7, 2024

8:00 am Check In, Morning Coffee & Refreshments

09:00 am

For Beginners in the ADC Field

Workshop A

Workshop A

The Chemistry & Properties of Antibody-Drug Conjugates: Linkers, Toxins & Their Effect on Therapeutic Index

Overviewing different classes of payloads and linker technologies employed by ADCs

Analyzing the synthetic challenges in preparation of linker-payload constructs and reactive groups necessary for attachment and release

Discussing the pros and cons of existing conjugation technologies.

Download the Full Event Guide for full details


Session Presented By NJ BIO

Workshop B
Workshop C

For Everyone in the ADC Field

Workshop D

Workshop D

Breaking Down Different ADC Design & Component Contributions to Set Up ADC Development for Success

Showcasing ADC case studies and designs tackling the same target - are there multiple pathways and designs to achieve success against the same targets?

Breaking down insights gained from recent ADC clinical trials Characterizing individual competent contributions as well as how all component work as a whole

Debating the valuable takeaways from different approaches to the same target

Download the Full Event Guide for full details


Robert Lutz, Chief Scientific Officer, Iksuda Therapeutics

Jutta Deckert, Vice President, Research & Development, Iksuda Therapeutics

Workshop E

12:00 pm Check In, Morning Coffee & Refreshments

For Beginners in the ADC Field

Workshop F

Workshop F

Delving Into the Chemistry & Art of ADC Linkers & Understanding Significance & Applications on ADC Properties & Performance

 

Linker chemistry 101: breaking down the current state of the science behind ADC linkers – bringing the chemistry to those designing and intending to design the ADCs

Contextualizing and processing linker data seen in literature and tackling a uniform linker nomenclature

Hearing case study examples of best linker technology currently under development and discussing the methodology of assessing performance

Breaking down the benefits and challenges of how best to leverage these as guidance in your ADC design

Download the Full Event Guide for full details


Paul Davis, President, Montgomery Holdings

Workshop G
Workshop H

For Everyone in the ADC Field

Workshop I

Workshop I

Using AI & Computational Approaches for Early-Stage Design & Late-Stage Development of Antibody Drug Conjugates

Exploring the multiscale mechanisms of ADC distribution, from subcellular to cellular, tissue, organ, and systemic biodistribution

Investigating AI methods in preclinical and clinical development of ADCs

Discussing the (sometimes) counterintuitive results of ADC efficacy in animals and the clinic

Reviewing the practical implementation of an ADC simulator to predict how ADC design impacts efficacy

Download the Full Event Guide for full details


Greg Thurber, Associate Professor & Chair, Graduate Education, University of Michigan

Dowdy Jackson, Chief Executive Officer, Jackson Consulting Group

Workshop J

4:00 pm End of Post-Conference Workshop Day